Advance therapies for rare diseases

Utmost rare pattern still warrant authorized treatments despite major advances in disquisition and furnishing the tools to understand their molecular base. Remedial modalities for restating advances in rare complaint knowledge into implicit medicines are known as orphan drugs. With this in mind, also are the advance antidotes, including small molecules, monoclonal antibodies, protein relief antidotes, oligonucleotides and gene and cell antidotes, as well as drug repurposing. For each system, we consider its strengths and manacle as a platform for rare complaint remedy expansion and describe clinical progress so far in developing drugs predicated on it. We also bat named overarching pattern in the expansion of antidotes for rare conditions, analogous as engagement of cases in the process and digital tools.


    Related Conference of Advance therapies for rare diseases

    November 21-22, 2024

    7th Pathology and Infectious Disease Conference

    Dubai, UAE
    November 28-29, 2024

    20th World Congress on Infection Prevention and Control

    Paris, France
    March 13-14, 2025

    9th International Conference on Rare Diseases

    Prague, Czech Republic
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands

    Advance therapies for rare diseases Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in